Company
Almirall
Almirall has 30 drugs tracked on RxWires: 7 post-market, 9 in Phase 3, 11 in Phase 2, 3 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Tiotropium | Post-Market | Pulmonary Disease, Chronic Obstructive |
| Tildrakizumab | Post-Market | Plaque Psoriasis |
| Tirbanibulin 2.5 mg ointment | Post-Market | Actinic Keratosis |
| Pidotimod | Post-Market | Recurrent Respiratory Tract Infections |
| lebrikizumab | Post-Market | Atopic Dermatitis |
| Tildrakizumab 100 mg Solution for Injection | Post-Market | Plaque Psoriasis |
| Tirbanibulin (Klisyri®) 10 mg/g ointment | Post-Market | Keratosis, Actinic |
| LAS41008 | Phase 3 | Plaque Psoriasis |
| 5-fluorouracil/salicylic acid | Phase 3 | Actinic Keratosis |
| P-3073 (calcipotriene 0.005%) | Phase 3 | Nail Psoriasis |
| LAS41005 | Phase 3 | Actinic Keratosis |
| KX2-391 Ointment 1% | Phase 3 | Actinic Keratoses |
| Sativex® | Phase 3 | Multiple Sclerosis |
| Dapsone Gel | Phase 3 | Acne Vulgaris |
| Sarecycline | Phase 3 | Acne Vulgaris |
| Cryotherapy + Tirbanibulin | Phase 3 | Keratosis |
| LAS41004 | Phase 2 | Psoriasis |
| LAD603 | Phase 2 | Alopecia Areata |
| LAD191 | Phase 2 | Hidradenitis Suppurativa |
| LAS41003 | Phase 2 | Candidiasis |
| 50 mg of KX2-391 Ointment 1% | Phase 2 | Actinic Keratosis |
| LAS 41004 | Phase 2 | Psoriasis |
| LAD328 | Phase 2 | Hidradenitis Suppurativa |
| LAS 41002 | Phase 2 | Atopic Eczema |
| 50 mg P005672-HCl | Phase 2 | Acne Vulgaris |
| Experimental Tazarotene Gel | Phase 2 | Nail Psoriasis |
| Cryotherapy | Phase 2 | Actinic Keratosis |
| Onabotulinum Toxin Type A - Phase 1b | Phase 1 | Atopic Dermatitis (AD) |
| LAS41008 120 mg / Fumaderm® 120 mg | Phase 1 | Psoriasis |
| LAD106 | Phase 1 |
Latest
No recent events.
Follow Almirall on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.